GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Capex-to-Operating-Income

Omnimmune Holdings (Omnimmune Holdings) Capex-to-Operating-Income : 0.00 (As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Omnimmune Holdings's Capital Expenditure for the three months ended in Sep. 2010 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2010 was $-0.23 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Omnimmune Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Omnimmune Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Capex-to-Operating-Income Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
Capex-to-Operating-Income
- - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omnimmune Holdings's Capex-to-Operating-Income

For the Biotechnology subindustry, Omnimmune Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's Capex-to-Operating-Income falls into.



Omnimmune Holdings Capex-to-Operating-Income Calculation

Omnimmune Holdings's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2009 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -1.522
=N/A

Omnimmune Holdings's Capex-to-Operating-Income for the quarter that ended in Sep. 2010 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.225
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnimmune Holdings  (GREY:OMMH) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Omnimmune Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines